DAX+0,07 % EUR/USD-0,03 % Gold-0,23 % Öl (Brent)-1,17 %

Rocket PharmaceuticalsAktie

WKN: A2JA9Q | Symbol: RCKT
20,465
 
USD
26.05.18 AMEX
+0,12 %
+0,025 USD
Mehr Daten anzeigen
NewsFlashAnzeige
Hot News - die vorprogrammierte Montags-Hausse - Kaufrausch auf Genehmigung!

Rocket Pharmaceuticals Chart

Neuigkeiten zur Rocket Pharmaceuticals Inc Aktie

ZeitTitel
18.05.18

Rocket Pharmaceuticals Presents Updated Data from Phase 1/2 Gene Therapy Trial of RP-L102 in Patients with Fanconi Anemia at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
17.05.18

Rocket Pharmaceuticals Announces Strategic Research Collaboration
15.05.18

Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. Food and Drug Administration Director of the Office of Orphan Products Development, as Vice President, Regulatory Policy and Patient Advocacy
11.05.18

Rocket Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights
08.05.18

Rocket Pharmaceuticals to Present at Upcoming Investor Conferences
30.04.18

Rocket Pharmaceuticals Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
06.03.18

Rocket Pharmaceuticals Reports Full Year 2017 Financial Results and Operational Highlights
05.03.18

Rocket Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference
07.02.18

Rocket Pharmaceuticals Announces Participation in a Fireside Chat at the Leerink Partners 7th Annual Global Healthcare Conference
17.10.17

Neothetics: Komplettexplosion nach SD-Einstieg – das ist der Grund!
12.10.17

Inotek Pharmaceuticals Announces Filing of Preliminary Proxy Statement for Proposed Merger with Clinical-stage Gene Therapy Company, Rocket Pharmaceuticals
18.09.17

Telit und Inotek mit +50% nach SD-Tipps – was ist jetzt zu tun?
14.09.17

Avatar CentTrader schrieb:
Genau. Hat sich überschnitten. Hatte mit dem Schreiben angefangen, mußte was anderes …
12.09.17

Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Therapies for Rare Diseases
03.08.17

Inotek Pharmaceuticals Corporation Reports Second Quarter 2017 Financial Results and Operational Highlights

Die neusten Nachrichten zu Rocket Pharmaceuticals

ZeitTitel
18.05.18
Rocket Pharmaceuticals Presents Updated Data from Phase 1/2 Gene Therapy Trial of RP-L102 in Patients with Fanconi Anemia at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
17.05.18
Rocket Pharmaceuticals Announces Strategic Research Collaboration
15.05.18
Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. Food and Drug Administration Director of the Office of Orphan Products Development, as Vice President, Regulatory Policy and Patient Advocacy
11.05.18
Rocket Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights
08.05.18
Rocket Pharmaceuticals to Present at Upcoming Investor Conferences
mehr Rocket Pharmaceuticals Nachrichten »

Diskussionen zur Rocket Pharmaceuticals Aktie

ZeitTitel
14.09.17
62
Inotek ein neuer Biotechstern ?

Indexzugehörigkeit von Rocket Pharmaceuticals

WertpapierPerf. %
Nasdaq
+0,13
NASDAQ Health Care Index
+0,16
NASDAQ Global Market Composite Index
+0,28
Nasdaq DM Ex Korea Small Cap Index Net Total Return
-0,35
Nasdaq DM Ex Korea Small Cap EUR Index Net Total Return
+0,24
Nasdaq DM Ex Korea Small Cap JPY Index Net Total Return
-0,12
Nasdaq DM Ex Korea Small Cap JPY Index
-0,12
Nasdaq DM Ex Korea Small Cap CAD Index
+0,28
Nasdaq US Small Cap Growth Index
0,00
Nasdaq DM Ex Korea Small Cap Index
-0,36
Alle zugehörigen Indizes »

Aktienkurs Rocket Pharmaceuticals A2JA9Q |

BörsenplatzAMEX
Letzter Kurs20,465USD
Performance+0,12 %
Kurszeit26.05.18
Eröffnung20,370USD
Tageshoch20,465USD
Tagestief20,370USD
Vortageskurs20,440USD
Volumen100,00Stk.
52-Wochen Hoch21,320USD
52-Wochen Tief3,651USD
Anzahl Trades4
Performance 1 Monat+23,73 %

Stammdaten zu Rocket Pharmaceuticals

NameRocket Pharmaceuticals Inc
KurznameRocket Pharmctc
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA2JA9Q
SymbolRCKT
BranchePharmaindustrie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl39,48 Mio.
Marktkapitalisierung807,97 Mio.USD

Performance Rocket Pharmaceuticals Aktie

ZeitKursPerf.
1 Tag20,465USD
+0,12 %
1 Woche19,840USD
+3,02 %
1 Monat16,520USD
+23,73 %
3 Monate18,230USD
+12,12 %
6 Monate9,800USD
+108,57 %
Lfd. Jahr10,480USD
+95,04 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameRocket Pharmaceuticals Inc
StadtLexington, MA
LandUSA USA
Webseitewww.inotekpharma.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Biotest
+0,20
2.
Biocryst Pharmaceuticals
+3,07
3.
Neurocrine Biosciences
+0,09
4.
Novavax
+2,42
5.
Sanochemia Pharmazeutika
-1,98
6.
Teva Pharmaceutical Industries (Spons. ADR)
+0,84
7.
CytoTools
-1,19
8.
Formycon
+0,41
9.
Coherus BioSciences
-1,39
10.
Lexicon Pharmaceuticals
+2,81